237 related articles for article (PubMed ID: 34130123)
1. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.
Czerwonka D; Urbaniak A; Sobczak S; Piña-Oviedo S; Chambers TC; Antoszczak M; Huczyński A
ChemMedChem; 2020 Jan; 15(2):236-246. PubMed ID: 31702860
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
5. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
[TBL] [Abstract][Full Text] [Related]
6. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents.
Antoszczak M
Eur J Med Chem; 2019 Mar; 166():48-64. PubMed ID: 30684870
[TBL] [Abstract][Full Text] [Related]
8. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
9. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
Yao HJ; Zhang YG; Sun L; Liu Y
Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis of SY-1 for investigation of breast cancer stem cell selectivity of C-ring-modified salinomycin analogues.
Huang X; Borgström B; Månsson L; Persson L; Oredsson S; Hegardt C; Strand D
ACS Chem Biol; 2014 Jul; 9(7):1587-94. PubMed ID: 24841425
[TBL] [Abstract][Full Text] [Related]
11. Semi-synthetic salinomycin analogs exert cytotoxic activity against human colorectal cancer stem cells.
Klose J; Kattner S; Borgström B; Volz C; Schmidt T; Schneider M; Oredsson S; Strand D; Ulrich A
Biochem Biophys Res Commun; 2018 Jan; 495(1):53-59. PubMed ID: 29107689
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
[TBL] [Abstract][Full Text] [Related]
13. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
14. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
15. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
[TBL] [Abstract][Full Text] [Related]
16. Ester derivatives of salinomycin efficiently eliminate breast cancer cells via ER-stress-induced apoptosis.
Kuran D; Flis S; Antoszczak M; Piskorek M; Huczyński A
Eur J Pharmacol; 2021 Feb; 893():173824. PubMed ID: 33347821
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance.
Yue W; Hamaï A; Tonelli G; Bauvy C; Nicolas V; Tharinger H; Codogno P; Mehrpour M
Autophagy; 2013 May; 9(5):714-29. PubMed ID: 23519090
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
19. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo.
Antoszczak M; Urbaniak A; Delgado M; Maj E; Borgström B; Wietrzyk J; Huczyński A; Yuan Y; Chambers TC; Strand D
Eur J Med Chem; 2018 Aug; 156():510-523. PubMed ID: 30025346
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]